Wednesday, February 10, 2010, 3:29am EST - Canadian Markets open in 6 hours and 1 minute.
To create a watchlist or portfolio of shares, Sign-in or Register

Novogen Limited (NVGN)

On Feb 9: 2.34 USD   0.00 (0.00%)  
MORE ON NVGN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Novogen Limited (NGM:NVGN) Delayed quote dataEdit
Last Trade: 2.34 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 2.34
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: N/A
Day's Range: N/A - N/A
52wk Range: 1.23 - 7.00
Volume: 0
Avg Vol (3m): 10,730.2
Market Cap: 47.79M
P/E (ttm): N/A
EPS (ttm): -0.81
Div & Yield: N/A (N/A%)
Novogen Limited (NVGN)
1d  5d  3m  6m  1y  2y  5y  max 
 Add NVGN to Portfolio   Download Data

HEADLINES
Marshall Edwards, Inc.'s Action Intended to Regain Compliance With Nasdaq Share Price Rule, Benefit Shareholders
Marketwire (Tue 3:30pm)
Marshall Edwards, Inc. Announces Resignation of Christopher Naughton From Board of Directors
Marketwire (Mon, Feb 8)
Analysis of Marshall Edwards, Inc.'s OVATURE Trial to Proceed Following Database Lock
Marketwire (Thu, Jan 21)
Culp, Novogen: Biggest Price Gainers (CFI, NVGN)
at The Wall Street Journal Online (Mon, Dec 7)
Marshall Edwards, Inc. Appoints Acting CEO
Marketwire (Tue, Dec 1)
Marshall Edwards, Inc.'s NV-128, a Novel mTOR Inhibitor, Demonstrates Good Safety Profile and High Anti-Cancer Activity In Vivo
Marketwire (Tue, Sep 29)
Marshall Edwards, Inc. Receives Nasdaq Notice of Minimum Bid Price Non-Compliance
Marketwire (Tue, Sep 22)
NOVOGEN LTD Financials
EDGAR Online Financials (Tue, Aug 18)
Marshall Edwards Licenses the Investigational Anti-Cancer Compound NV-128 From Novogen Limited
Marketwire (Wed, Aug 5)
Novogen Director Retires
Marketwire (Thu, Jul 30)
More Headlines for NVGN...

ANALYST
EPS Est (next year) (Dec-69) : N/A
EPS Est (in 2 years) (Dec-69) : N/A
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Novogen Limited and its subsidiaries engage in the research and development of pharmaceutical products, and marketing of consumer healthcare products. The company’s consumer healthcare products comprise Promensil, a range of natural products ...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices